Alzheimer's Disease Trial, Recruiting NCT06403345 Sponsor: Indiana University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06403345
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People living with memory challenges:

  • You are 45 years of age or older
  • You have memory problems or difficulties with thinking
  • You have access to a phone (mobile or landline) and are able to use it

Study partners (someone who joins alongside the person with memory challenges):

  • You are 18 years of age or older
  • You speak Spanish or English
  • You have been chosen by the person with memory challenges as someone they feel comfortable with and would like to have in the study with them

Outdoor activity professionals:

  • You are 18 years of age or older
  • You have at least 1 year of experience leading or providing outdoor activities

Who may not be able to join:

(For people living with memory challenges)

  • You have heart failure with symptoms beyond feeling completely normal during everyday activities, such as unusual tiredness, a racing heart, or shortness of breath (confirm with trial site)
  • You have a heart condition where your heartbeat is irregular and is difficult to control
  • You have coronary artery disease (blocked arteries in the heart) that is difficult to control
  • Your doctor has told you not to do physical activity because of a heart condition or any other medical condition
  • You are currently having cancer treatment that involves regular infusion chemotherapy (given through a drip/IV) or daily radiation treatments
  • Your doctor has told you not to do physical activity because of your cancer, cancer treatment, or any other medical condition
  • You have blacked out, fainted, or lost consciousness due to a head injury in the past 12 months
  • You regularly experience signs of low blood sugar (such as shakiness, dizziness, or confusion) after exercise or daily activities
  • You have been hospitalised 2 or more times in the past 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 July 2024
Est. completion
30 May 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility intervention completion rate; Other Feasibility measures; Acceptability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov